Punjab Recalls Four Medicine Batches Over Quality Concerns

Punjab health authorities have issued a recall of four medicine batches after provincial drug testing laboratories declared them substandard and adulterated.

Key points

• 70 Individuals Fall Ill After Eating Suspected Contaminated Food at Engagement Ceremony.
• Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
• According to the notice, DryGlit 120mL syrup was discovered to be substandard as its ethylene glycol content exceeded permissible limits.
• Add as a preferredSource on Google Follow on Google News Join WhatsApp.
• The products include DryGlit syrup, Trezine tablets, Zinad tablets and Bemin tablets.

In practice, the products include DryGlit syrup, Trezine tablets, Zinad tablets and Bemin tablets.

According to the notice, DryGlit 120mL syrup was discovered to be substandard as its ethylene glycol content exceeded permissible limits. The affected batches are S13326 and S13426, both with an expiry date of June 2028. Obesity Linked to 229 Diseases, Experts Warn in Pakistan.

Meanwhile, the remaining three products were classified as adulterated: Trezine. It contains Cetirizine 10mg, batch number 307, expiring in April 2027; Zinad, which contains Tizanidine 2mg, batch 5F001, expiring in June 2028; and Bemin, which contains Mecobalamin 500mcg, batch 093, expiring in September 2027.

Punjab authorities have instructed pharmacies, wholesalers, distributors and healthcare facilities to immediately stop dispensing the affected batches.

They have additionally been asked to report existing stocks and consumption records to the relevant drug inspectors.

In practice, the notice directs manufacturers and market authorisation holders to initiate recalls and submit details including a recall assessment, root-cause analysis and corrective and preventive action intends.

For context, the provincial authorities have additionally called on enhanced surveillance throughout the medicine supply chain to ensure traceability of the affected products.

Notably, the administration has advised consumers and patients to stop using the listed batches immediately, warning that they may pose a risk to health. Stay Connected with ProPakistani. Obtain the latest news and stories wherever you prefer. Follow on Google Discover.

Taken together, the developments around punjab Recalls Four Medicine Batches Over Quality Concerns point to a situation that is still moving, and the coming days should bring more clarity.